RALEIGH, N.C., Sept. 27, 2016 -- NC HIFU, a division of UroCare, PLLC, led by urologist Frank Tortora, MD elected to partner with HIFU Prostate Services, LLC (HPS), the leading provider of HIFU technology to physician’s practices in the United States. Dr. Tortora is one of the country’s leading HIFU physicians and has treated men offshore with HIFU for nearly 8 years prior to FDA-clearance of the Sonablate® HIFU technology. Dr. Tortora has been treating men in the greater Raleigh area with Sonablate® HIFU since the beginning of this year.
HIFU, which stands for High Intensity Focused Ultrasound, is a non-surgical, radiation-free, outpatient procedure that uses focused sound waves to heat and destroy diseased tissue in the prostate gland. In October 2015, the FDA cleared the Sonablate® technology for the ablation of prostatic tissue. Sonablate® HIFU leads the industry in prostate tissue ablation with features such as Tissue Change Monitoring, Neurovascular Bundle Detection, Rectal Wall Monitoring, Reflectivity Index Monitoring, and MRI Fusion. No other HIFU device for prostate ablation offers all of these features to maintain patient safety and the highest level of quality care.
Dr. Tortora is a recognized expert in robotic surgery and HIFU technology for prostate cancer. He is sought after by national developers of new urological procedures and treatments and has helped in developing medical and surgical techniques to aid in the treatment of male sexual dysfunction. He has earned the title of experienced physician and proctor of Sonablate® HIFU by the device manufacturer, SonaCare Medical, LLC. Dr. Tortora is affiliated with the UNC School of Medicine as a Clinical Associate Professor in the departments of Surgery and Family Practice.
“As the leader in providing the HIFU treatment to men in the Raleigh area, we are excited to be partnering with HPS,” said Dr. Tortora. “This is a great opportunity for NC HIFU as well as for HPS, the country’s leading HIFU provider; and for the Raleigh community.”
“Out of the top ten HIFU physicians in the in the U.S., Dr. Tortora is the seventh to choose to partner with HPS. This means HPS has the largest pool of trained HIFU physicians and proctors in the country,” said John McLean chief operating officer with HIFU Prostate Services.
“We are excited that the greater Raleigh area is our tenth location to offer HIFU to patients with localized prostate cancer and our second location in the Carolinas in addition to Charlotte. HPS already leads the country in providing access to HIFU technology and training to physicians, and we are excited about adding NC HIFU and Dr. Tortora,” continued McLean.
About HIFU Prostate Services, LLC
HIFU Prostate Services (HPS) was founded to provide men access to a less invasive treatment option for prostate cancer that has the ability to eliminate cancer and preserve patient quality of life. Our mission is to deliver the highest quality of care, support, and technology to the patient and to the urology community for the treatment of localized prostate cancer using Sonablate® HIFU. The company is headquartered in Charlotte, NC. http://www.hifuprostateservices.com.
About NC HIFU
NC HIFU, a division of UroCare, PLLC, was set up to help men in the Carolinas gain access to Sonablate® HIFU, the leading technology in prostate tissue ablation. UroCare, PLLC provides medical care and treatment options for a variety of male and female urological conditions and non-covered benefits at a competitive price. http://www.nchifu.com
Media Contact: John McLean (704) 248-7557


Instagram Outage Disrupts Thousands of U.S. Users
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



